Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs

References

• Braithwaite, R. S., Meltzer, D. O., King Jr, J. T., Leslie, D., & Roberts, M. S. (2008). What does the value of modern medicine say about the 50,000 per quality-adjusted life-year decision rule? Medical Care, 46(4), 349–356. doi: 10.1097/MLR.0b013e31815c31a7
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2011). Understanding the HIV care continuum. Retrieved February 17, 2016, from http://www.cdc.gov/hiv/statistics/systems/mmp/resources.html.
   Google Scholar
• Creese, A., Floyd, K., Alban, A., & Guinness, L. (2002). Cost-effectiveness of HIV/AIDS interventions in Africa: A systematic review of the evidence. The Lancet, 359(9318), 1635–1642. doi: 10.1016/S0140-6736(02)08595-1
   PubMed Web of Science ®Google Scholar
• Farnham, P. G., Holtgrave, D. R., Gopalappa, C., Hutchinson, A. B., & Sansom, S. L. (2013). Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. JAIDS Journal of Acquired Immune Deficiency Syndromes, 64(2), e15–e18. doi: 10.1097/QAI.0b013e3182a5c8d4
   PubMed Web of Science ®Google Scholar
• Gold, M. R., Siegel, J. E., Russell, L. B., Weinstein, Mc., & Others. (1996). Cost-effectiveness in health and medicine: Report of the panel on cost-effectiveness in health and medicine. New York, NY: Oxford University Press.
   Google Scholar
• Gopalappa, C., Farnham, P. G., Hutchinson, A. B., & Sansom, S. L. (2012). Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons. JAIDS Journal of Acquired Immune Deficiency Syndromes, 61(1), 99–105. doi: 10.1097/QAI.0b013e31825bd862
   PubMed Web of Science ®Google Scholar
• Hogan, D. R., Baltussen, R., Hayashi, C., Lauer, J. A., & Salomon, J. A. (2005). Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ, 331(7530), 1431–1437. doi: 10.1136/bmj.38643.368692.68
   PubMed Web of Science ®Google Scholar
• Holtgrave, D. R. (1998). Handbook of economic evaluation of HIV prevention programs (AIDS Prevention and Mental Health) (1st ed.). New York: Springer. Retrieved from http://www.amazon.com/Handbook-Economic-Evaluation-Prevention-Programs/dp/0306457490/ref=sr_1_2?s=books&ie=UTF8&qid=1451962811&sr=1-2
   Google Scholar
• Holtgrave, D. R., Briddell, K., Little, E., Bendixen, A. V., Hooper, M., Kidder, D. P., … Aidala, A. (2007). Cost and threshold analysis of housing as an HIV prevention intervention. AIDS and Behavior, 11(2), 162–166. doi: 10.1007/s10461-007-9274-z
   PubMed Web of Science ®Google Scholar
• Holtgrave, D. R., Hall, H. I., Wehrmeyer, L., & Maulsby, C. (2012). Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: A closing window for success? AIDS and Behavior, 16(6), 1365–1372. doi: 10.1007/s10461-012-0207-0
   PubMed Web of Science ®Google Scholar
• Holtgrave, D. R., Wolitski, R. J., Pals, S. L., Aidala, A., Kidder, D. P., Vos, D., … Bendixen, A. V. (2013). Cost-utility analysis of the housing and health intervention for homeless and unstably housed persons living with HIV. AIDS and Behavior, 17(5), 1626–1631. doi: 10.1007/s10461-012-0204-3
   PubMed Web of Science ®Google Scholar
• Kim, J. J., Maulsby, C., Zulliger, R., Jain, K., Charles, V., Riordan, M., … Holtgrave, D. R. (2015). Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States. AIDS and Behavior, 19(10), 1735–1741. doi:10.1007/s10461-015-1124-9.
   PubMed Web of Science ®Google Scholar
• Losina, E., Touré, H., Uhler, L. M., Anglaret, X., Paltiel, A. D., Balestre, E., … Freedberg, K. A. (2009). Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: A Cote d’Ivoire appraisal. PLoS Medicine, 6(10), e1000173. doi: 10.1371/journal.pmed.1000173
   PubMed Web of Science ®Google Scholar
• Marseille, E., Giganti, M. J., Mwango, A., Chisembele-Taylor, A., Mulenga, L., Over, M., … Stringer, J. S. A. (2012). Taking ART to scale: Determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PloS One, 7(12), e51993. doi: 10.1371/journal.pone.0051993
   PubMed Web of Science ®Google Scholar
• Marseille, E., Kahn, J. G., Pitter, C., Bunnell, R., Epalatai, W., Jawe, E., … Mermin, J. (2009). The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Applied Health Economics and Health Policy, 7(4), 229–243. doi: 10.1007/BF03256157
   PubMedGoogle Scholar
• Metsch, L. R., Pereyra, M., Messinger, S., del Rio, C., Strathdee, S. A., Anderson-Mahoney, P., … Gardner, L. (2008). HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clinical Infectious Diseases, 47(4), 577–584. doi: 10.1086/590153
   PubMed Web of Science ®Google Scholar
• ONAP. (2010). National HIV/AIDS strategy for the United States. Retrieved August 1, 2015, from http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.
   Google Scholar
• ONAP. (2015). National HIV/AIDS strategy for the United States. Retrieved May 12, 2014, from http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.
   Google Scholar
• Renaud, A., Basenya, O., De Borman, N., Greindl, I., & Meyer-Rath, G. (2009). The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi. AIDS Care, 21(11), 1388–1394. doi: 10.1080/09540120902884042
   PubMed Web of Science ®Google Scholar
• Russell, L. B., Gold, M. R., Siegel, J. E., Daniels, N., & Weinstein, M. C. (1996). The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA, 276(14), 1172–1177. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8827972. doi: 10.1001/jama.1996.03540140060028
   PubMed Web of Science ®Google Scholar
• Salzmann, P., Kerlikowske, K., & Phillips, K. (1997). Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Annals of Internal Medicine, 127(11), 955–965. doi: 10.7326/0003-4819-127-11-199712010-00001
   PubMed Web of Science ®Google Scholar
• Shrestha, R. K., Gardner, L., Marks, G., Craw, J., Malitz, F., Giordano, T. P., … Mugavero, M. (2015). Estimating the cost of increasing retention in care for HIV-infected patients: Results of the CDC/HRSA retention in care trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(3), 345–350. doi: 10.1097/QAI.0000000000000462
   PubMed Web of Science ®Google Scholar
• Silva, A., Glick, N. R., Lyss, S. B., Hutchinson, A. B., Gift, T. L., Pealer, L. N., … Whitman, S. (2007). Implementing an HIV and sexually transmitted disease screening program in an emergency department. Annals of Emergency Medicine, 49(5), 564–572. doi: 10.1016/j.annemergmed.2006.09.028
   PubMed Web of Science ®Google Scholar
• Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., … Mermin, J. H. (2015). Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Medicine, 175(4), 588–596. doi: 10.1001/jamainternmed.2014.8180
   PubMed Web of Science ®Google Scholar
• Trentacoste, N. D., Holtgrave, D. R., Collins, C., & Abdul-Quader, A. (2004). Disseminating effective behavioral interventions for HIV prevention: A cost analysis of a risk-reduction intervention for drug users. Journal of Public Health Management and Practice, 10(2), 130–139. doi: 10.1097/00124784-200403000-00007
   PubMedGoogle Scholar
• Ubel, P. A., Hirth, R. A., Chernew, M. E., & Fendrick, A. M. (2003). What is the price of life and why doesn’t it increase at the rate of inflation? Archives of Internal Medicine, 163(14), 1637–1641. doi: 10.1001/archinte.163.14.1637
   PubMed Web of Science ®Google Scholar
• Walker, D. (2003). Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: Is there an evidence base? Health Policy and Planning, 18(1), 4–17. doi: 10.1093/heapol/18.1.4
   PubMed Web of Science ®Google Scholar
• Weinstein, M. C. (2008). How much are Americans willing to pay for a quality-adjusted life year? Medical Care, 46(4), 343–345. doi: 10.1097/MLR.0b013e31816a7144
   PubMed Web of Science ®Google Scholar
• Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA, 276(15), 1253–1258. doi: 10.1001/jama.1996.03540150055031
   PubMed Web of Science ®Google Scholar
• WHO-CHOICE. (2014). Cost effectiveness thresholds. Retrieved August 26, 2014, from http://www.who.int/choice/costs/CER_thresholds/en/.
   Google Scholar
• Winkelmayer, W. C., Weinstein, M. C., Mittleman, M. A., Glynn, R. J., & Pliskin, J. S. (2002). Health economic evaluations: The special case of end-stage renal disease treatment. Medical Decision Making, 22(5), 417–430. doi: 10.1177/027298902320556118
   PubMed Web of Science ®Google Scholar